TorayQuestion for all longs? How much do you think Toray would be willing to buy Spectral out for if it delivered a FDA approval where they achieved a 25 to 30 percent absolute benefit? Now add in a FDA approved new and exclusive pump that measures endotoxins quickly and easily as blood is filtered through PMX column?
The trial numbers thus far tell a nice story, even though the company remains quiet. Also noticed that in the companies marketing presentation that they did not include any revenues for the EAA outside of N/A.....nor is any potential revenue for the pump indicated. Who here has done the math themselves? Look forward to further insight from resident posters who may also have other things for consideration.....